Key result
Higher serum magnesium is linked to blunted pro-atherogenic lipid effects on carotid thickness in CKD.
Why the study?
Classical cardiovascular risk factors show paradoxical effects in chronic kidney disease, prompting investigation into the relationships of magnesium and lipid parameters with atherosclerosis in this population.
Do magnesium levels modify the effect of lipid parameters on carotid intima media thickness in patients with chronic kidney disease?
Cross-Sectional (n=1,754)
Yes
Do magnesium levels modify the effect of lipid parameters on carotid intima media thickness in patients with chronic kidney disease?
High magnesium levels appear to mitigate the pro-atherosclerotic effects of high triglycerides and LDL cholesterol on carotid intima media thickness in patients with chronic kidney disease.
Answers are grounded in this paper and cite their sources.
May blunt lipid effects on cIMT in CKD when magnesium >1 mmol/L; hypothesis-generating and requires prospective trials before practice change.
Classical risk factors of atherosclerosis in the general population show paradoxical effects in chronic kidney disease (CKD) patients. Thus, low low-density lipoprotein (LDL) cholesterol levels have been associated with worse cardiovascular outcomes. Magnesium (Mg) is a divalent cation whose homeostasis is altered in CKD. Furthermore, Mg levels have been associated with cardiovascular health. The present study aims to understand the relationships of Mg and lipid parameters with atherosclerosis in CKD. In this analysis, 1754 participants from the Observatorio Nacional de Atherosclerosis en Nefrologia (NEFRONA) cohort were included. Carotid intima media thickness (cIMT) was determined in six arterial territories, and associated factors were investigated by linear regression. cIMT correlated positively with being male, Caucasian, a smoker, diabetic, hypertensive, dyslipidemic and with increased age, BMI, and triglyceride levels, and negatively with levels of HDL cholesterol. First-order interactions in linear regression analysis showed that Mg was an effect modifier on the influence of lipidic parameters. Thus, cIMT predicted values were higher when triglycerides or LDL levels were high and Mg levels were low. On the contrary, when Mg levels were high, this effect disappeared. In conclusion, Mg acts as an effect modifier between lipidic parameters and atherosclerotic cardiovascular disease. Therefore, Mg levels, together with lipidic parameters, should be taken into account when assessing atherosclerotic risk.
No takes yet. Share an insight, caveat, or question.
Cambray et al. (2020) conducted a cross-sectional in Chronic kidney disease (CKD) and atherosclerosis (n=1,754). Serum magnesium levels and interaction with lipid parameters (LDL-C, HDL-C, triglycerides, total cholesterol) vs. Low vs. high (>1 mmol/L) serum magnesium levels across varying lipid levels was evaluated on Carotid intima-media thickness (cIMT) in arterial territories without atheroma plaque (p=<0.05). Serum magnesium modifies lipid effects on carotid intima-media thickness in CKD, abolishing the pro-atherogenic impact of high triglycerides and LDL-C at levels >1 mmol/L.
Synapse has enriched 10 related papers. Consider them for comparative context: